Efficient plasma protein capture
at high yields and purities

PlasmaCap EBA is an innovative expanded bed adsorption (EBA) technology for plasma protein capture. It was developed by a dedicated team of experts as an attractive means to extract valuable plasma proteins directly from plasma or fractionated plasma materials by providing:

  • Efficient protein capture
  • High plasma protein capture yields
  • High purity plasma proteins

Therapure is developing this technology to enhance the cost-effectiveness and reduce the operational involvement of capturing plasma proteins for:

  • Plasma fractionators
  • Plasma protein manufacturers
  • Biopharma manufacturers
  • Other parties interested in capturing plasma proteins

The innovative features of PlasmaCap EBA can provide advantages as well as eliminate many concerns that arise when operating conventional chromatography columns for plasma protein manufacturing.

Learn more about the PlasmaCap EBA technology.

To learn more about our
PlasmaCap EBA technology,
its applications, and partnering
opportunities, please contact us.

therapurebio-plasmacap therapurebio-plasmacap

Disclaimer | Privacy Policy | Accessibility | Sitemap

PlasmaCap EBA is a trademark of Therapure Biopharma Inc.

Copyright ©2013 Therapure Biopharma Inc.